Medicare Data Offers Positive News For Drug-Eluting Stent Makers
This article was originally published in The Gray Sheet
Executive Summary
Widespread adoption of drug-eluting stents has reduced repeat revascularization procedures without increasing the risk of death or heart attack, a retrospective study of 67,000 Medicare patients suggests
You may also be interested in...
Vienna Meeting Goes Relatively Smoothly For Drug-Eluting Stent Makers
Drug-eluting stent manufacturers did not have to answer to any surprise negative results at the European Society of Cardiology conference in Vienna this year and, in fact, got some good news from an ongoing registry
Off-Label Drug-Eluting Stent Data Weak; Label Should Be Revised – Panel
FDA panel members recommended changes to drug-eluting stent labeling that would more clearly indicate differences between on- and off-label use. However, they found that the data was insufficient to make definitive conclusions about risks for unapproved applications, which account for the majority of stent placements
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.